Amyn A Habib Selected Research

Amyn A Habib Research Topics

Disease

25	Neoplasms (Cancer) 12/2021 - 01/2003
13	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2006
8	Glioma (Gliomas) 12/2021 - 01/2006
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2009
2	Neoplasm Metastasis (Metastasis) 11/2019 - 01/2019
2	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 05/2013 - 04/2010
2	Carcinogenesis 10/2010 - 01/2006
1	Malignant Pleural Effusion 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 10/2021
1	Adenocarcinoma 10/2021
1	Esophageal Squamous Cell Carcinoma 10/2021
1	Bites and Stings (Sting) 11/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 03/2014
1	Oligodendroglioma 03/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2014
1	Necrosis 01/2013
1	Hypoxia (Hypoxemia) 04/2009
1	Inflammation (Inflammations) 08/2008

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 12/2021 - 01/2013
6	epidermal growth factor receptor VIIIIBA 12/2017 - 01/2006
6	ErbB Receptors (EGF Receptor)IBA 08/2017 - 01/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2009
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2008
4	Temozolomide (Temodar)FDA LinkGeneric 12/2019 - 08/2013
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	PhosphatidylserinesIBA 11/2019 - 06/2016
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2019 - 04/2010
3	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 10/2009 - 05/2007
2	Phosphotransferases (Kinase)IBA 10/2021 - 03/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2017
2	Liposomes (Liposome)IBA 11/2019 - 06/2016
2	IonsIBA 01/2019 - 10/2010
2	Contrast MediaIBA 01/2017 - 06/2016
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2014 - 05/2009
2	LigandsIBA 08/2013 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 05/2007
2	2-aminothiazoleIBA 04/2009 - 05/2007
2	NF-kappa B (NF-kB)IBA 04/2009 - 08/2008
1	Etanercept (Enbrel)FDA Link 12/2021
1	CrizotinibIBA 12/2021
1	Thalidomide (Thalomid)FDA Link 12/2021
1	Neutralizing AntibodiesIBA 12/2021
1	navitoclaxIBA 12/2021
1	Prednisone (Sone)FDA LinkGeneric 12/2021
1	hydroxyitraconazoleIBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 10/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 10/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Lapatinib (GW572016)FDA Link 10/2021
1	Ribosomal Protein S6IBA 10/2021
1	Antiviral Agents (Antivirals)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2019
1	Interferon Type IIBA 11/2019
1	CarbonIBA 01/2019
1	Proto-Oncogene Proteins c-metIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Protons (Proton)IBA 01/2019
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 12/2017
1	Interleukin-13 Receptor alpha2 SubunitIBA 12/2017
1	Axl Receptor Tyrosine KinaseIBA 08/2017
1	JNK Mitogen-Activated Protein KinasesIBA 08/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2017
1	AntibodiesIBA 01/2017
1	AntigensIBA 06/2016
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 03/2014
1	dactolisibIBA 03/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2014
1	Radiation-Sensitizing AgentsIBA 03/2014
1	Hematoxylin (Haematoxylon)IBA 03/2014
1	DNA-Activated Protein KinaseIBA 03/2014
1	vasectrin IIIIBA 03/2014
1	NestinIBA 03/2014
1	Biological ProductsIBA 05/2013
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 05/2013
1	SphingolipidsIBA 01/2013
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2013
1	CeramidesIBA 01/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2010
1	Deoxyglucose (2 Deoxy D glucose)IBA 11/2009
1	Coloring Agents (Dyes)IBA 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 11/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2009
1	TOR Serine-Threonine KinasesIBA 05/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2009
1	Matrix Metalloproteinases (MMPs)IBA 04/2009
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2006
1	Transforming Growth Factor alpha (TGF-alpha)IBA 01/2006
1	Heparin (Liquaemin)FDA LinkGeneric 01/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2009
5	Radiotherapy 12/2021 - 05/2013
2	Immunotherapy 01/2022 - 11/2019
1	Aftercare (After-Treatment) 05/2013
1	Combined Modality Therapy 05/2013
1	Image-Guided Radiotherapy 05/2013